Ex-CFTC Commissioner Quintenz Joins SUI Group as Crypto's ‘Shadow Regulator’ Network Grows

7 January 2026 - 12:30 CET
Brian Quintenz CFTC Chair
Credit: Bloomberg / Contributor

SUI Group (Nasdaq: SUIG) has appointed former US Commodity Futures Trading Commission (CFTC) Commissioner Brian Quintenz to its board, securing a high-level regulatory veteran as the firm aggressively expands its SUI-focused treasury strategy.

Quintenz, who also served as global head of policy at a16z crypto, joined the Nasdaq-listed firm as an independent director on 5 Jan. In a statement, SUI Group, which operates as a corporate treasury vehicle for the SUI token, similar to the Strategy (MSTR) model for Bitcoin, stated the appointment would bolster its "regulatory and policy leadership."

The talent arbitrage

The move highlights a broader trend: crypto firms are no longer just lobbying regulators; they are hiring them.

Quintenz’s appointment follows a string of high-profile departures and returns linked to the derivatives watchdog. In December, acting CFTC Chair Caroline Pham announced she would join crypto payments firm MoonPay as Chief Legal Officer, marking one of the sector's most significant regulator-to-industry transfers.

Simultaneously, the agency is re-arming itself. CFTC Chair Michael Selig recently brought back Amir Zaidi, a key architect of the first regulated Bitcoin futures contracts, as Chief of Staff.

Institutionalizing the bridge

Quintenz’s career illustrates how tightly interwoven these networks have become. Beyond his CFTC tenure, he sits on the board of Kalshi, a regulated prediction markets exchange.

His role at SUI Group is strategic. As the firm attempts to position itself as an institutional-grade bridge between public equity markets and the Sui blockchain, having a former regulator on the audit committee provides a layer of legitimacy that is difficult to buy with marketing alone.

As regulatory lines around crypto custody and market structure harden, this cross-pollination is shifting from a "conflict of interest" narrative to an operational necessity. For firms like SUI Group, regulatory DNA is now a capital asset.